
LeMaitre Vascular LMAT
$ 83.95
-0.46%
Quarterly report 2025-Q3
added 11-07-2025
LeMaitre Vascular Accounts Payables 2011-2025 | LMAT
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables LeMaitre Vascular
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.76 M | 3.73 M | 2.9 M | 2.34 M | 2.39 M | 2.6 M | 1.73 M | 1.54 M | 1.22 M | 1.37 M | 1.13 M | 1.24 M | 1.06 M | 981 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.73 M | 981 K | 1.86 M |
Quarterly Accounts Payables LeMaitre Vascular
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.46 M | 4.91 M | 2.18 M | 1.65 M | 2 M | - | 4.37 M | 3.52 M | 3.37 M | 2.9 M | 2.85 M | - | 2.19 M | 2.34 M | 3.14 M | 2.06 M | 2.56 M | 2.39 M | 2.39 M | 2.39 M | 2.39 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 1.73 M | 1.73 M | 1.73 M | 1.73 M | 1.54 M | 1.54 M | 1.54 M | 1.54 M | 1.22 M | 1.22 M | 1.22 M | 1.22 M | 1.37 M | 1.37 M | 1.37 M | 1.37 M | 1.13 M | 1.13 M | 1.13 M | 1.13 M | 1.24 M | 1.24 M | 1.24 M | 1.24 M | 1.06 M | 1.06 M | 1.06 M | 1.06 M | 981 K | 981 K | 981 K | 981 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.91 M | 981 K | 1.9 M |
Accounts Payables of other stocks in the Medical instruments industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
968 M | $ 19.32 | 1.05 % | $ 9.85 B | ||
|
Becton, Dickinson and Company
BDX
|
1.97 B | $ 196.18 | -0.01 % | $ 56.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
1.55 M | $ 5.47 | -0.01 % | $ 110 M | ||
|
Harvard Bioscience
HBIO
|
5.55 M | $ 0.71 | -1.78 % | $ 30.1 M | ||
|
Repro Med Systems
KRMD
|
975 K | $ 6.25 | -3.55 % | $ 285 M | ||
|
iRhythm Technologies
IRTC
|
7.22 M | $ 177.0 | 0.68 % | $ 5.52 B | ||
|
ICU Medical
ICUI
|
148 M | $ 148.17 | 0.81 % | $ 3.61 B | ||
|
AtriCure
ATRC
|
25 M | $ 40.7 | 0.37 % | $ 1.91 B | ||
|
Atrion Corporation
ATRI
|
6.63 K | - | - | $ 810 M | ||
|
electroCore
ECOR
|
2.16 M | $ 4.93 | 1.54 % | $ 27.2 K | ||
|
AngioDynamics
ANGO
|
33.3 M | $ 13.12 | -0.3 % | $ 536 M | ||
|
Merit Medical Systems
MMSI
|
68.5 M | $ 87.36 | -0.03 % | $ 5.09 B | ||
|
The Cooper Companies
COO
|
300 M | $ 82.55 | -0.03 % | $ 16.4 B | ||
|
Glaukos Corporation
GKOS
|
13.4 M | $ 116.08 | -0.56 % | $ 5.62 B | ||
|
Haemonetics Corporation
HAE
|
67 M | $ 80.39 | 0.36 % | $ 4.05 B | ||
|
InfuSystem Holdings
INFU
|
8.34 M | $ 8.93 | -1.71 % | $ 184 M | ||
|
Masimo Corporation
MASI
|
253 M | $ 132.7 | -0.44 % | $ 7.07 B | ||
|
OraSure Technologies
OSUR
|
8.17 M | $ 2.43 | - | $ 181 M | ||
|
Intuitive Surgical
ISRG
|
193 M | $ 578.08 | 0.16 % | $ 205 B | ||
|
Microbot Medical
MBOT
|
357 K | $ 2.16 | -0.88 % | $ 22 M | ||
|
Milestone Scientific
MLSS
|
780 K | $ 0.29 | -1.41 % | $ 23.1 M | ||
|
Nephros
NEPH
|
873 K | $ 4.98 | -4.78 % | $ 51.7 M | ||
|
STERIS plc
STE
|
281 M | $ 255.64 | 0.02 % | $ 25.2 B | ||
|
NeuroMetrix
NURO
|
363 K | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
175 M | $ 21.99 | -0.05 % | $ 3.79 B | ||
|
Predictive Oncology
POAI
|
1.14 M | - | - | $ 32.4 M | ||
|
Pro-Dex
PDEX
|
4.61 M | $ 39.33 | -2.65 % | $ 129 M | ||
|
Utah Medical Products
UTMD
|
769 K | $ 56.66 | 0.66 % | $ 206 M | ||
|
Pulse Biosciences
PLSE
|
1.84 M | $ 14.45 | -2.76 % | $ 694 M | ||
|
ResMed
RMD
|
159 M | $ 245.14 | 0.3 % | $ 35.8 B | ||
|
DENTSPLY SIRONA
XRAY
|
241 M | $ 11.47 | 3.66 % | $ 2.33 B | ||
|
Repligen Corporation
RGEN
|
19.6 M | $ 165.37 | -0.18 % | $ 9.21 M | ||
|
BioLife Solutions
BLFS
|
3.57 M | $ 24.95 | -1.81 % | $ 1.15 B | ||
|
Stereotaxis
STXS
|
3.19 M | $ 2.46 | 1.23 % | $ 199 M | ||
|
STAAR Surgical Company
STAA
|
16.7 M | $ 23.37 | -1.1 % | $ 1.15 B | ||
|
Retractable Technologies
RVP
|
4.29 M | $ 0.82 | -0.51 % | $ 24.5 M | ||
|
Teleflex Incorporated
TFX
|
141 M | $ 122.75 | 0.7 % | $ 5.75 B | ||
|
West Pharmaceutical Services
WST
|
239 M | $ 274.28 | -0.95 % | $ 20 B |